Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189,977 | 192,060 | 190,339 | 113,556 | 113,396 |
| Marketable Securities | 24,741 | 39,387 | 63,334 | 116,039 | 138,259 |
| Receivables | 96 | 136 | 492 | 588 | 395 |
| Other current assets | 4,269 | 3,699 | 5,880 | 2,955 | 0 |
| TOTAL | $230,019 | $246,232 | $270,236 | $244,070 | $264,601 |
| Non-Current Assets | |||||
| PPE Net | 6,217 | 6,472 | 6,789 | 6,675 | 7,161 |
| Other Non-Current Assets | 3,653 | 4,215 | 4,771 | 5,322 | 5,864 |
| TOTAL | $9,870 | $10,687 | $11,560 | $11,997 | $13,025 |
| Total Assets | $239,889 | $256,919 | $281,796 | $256,067 | $277,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,076 | 1,556 | 4,299 | 766 | 1,911 |
| Accrued Expenses | 13,390 | 12,222 | 13,777 | 15,748 | 14,046 |
| TOTAL | $25,201 | $21,837 | $31,527 | $31,394 | $28,795 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 8,735 | 8,059 | 13,451 | 14,880 | 12,838 |
| Other Non-Current Liabilities | 959 | 1,629 | 2,303 | 2,968 | 3,610 |
| TOTAL | $41,689 | $44,887 | $36,447 | $39,824 | $44,688 |
| Total Liabilities | $66,890 | $66,724 | $67,974 | $71,218 | $73,483 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,654 | 44,257 | 44,189 | 44,148 | 39,431 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -374,891 | -350,349 | -319,695 | -297,150 | -271,495 |
| Other shareholders' equity | -147 | -379 | -598 | -1,175 | -1,703 |
| TOTAL | $172,999 | $190,195 | $213,822 | $184,849 | $204,143 |
| Total Liabilities And Equity | $239,889 | $256,919 | $281,796 | $256,067 | $277,626 |